Anandamide-induced cell death in primary neuronal cultures: Role of calpain and caspase pathways

Cell Death and Differentiation

Volumn 11, Issue 10, 2004, Pages 1121-1132

  Movsesyan, V A ^a   Stoica, B A ^a   Yakovlev, A G ^a   Knoblach, S M ^a   Lea IV, P M ^a   Cernak, I ^a   Vink, R ^a   Faden, A I ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arachidonoylethanolamide; Calpain; Caspase; Cerebellar granule cells; Cortical neurons; Neuronal death

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CALCIUM; CALPAIN; CALPASTATIN; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CAPSAZEPINE; CASPASE; CASPASE 3; CASPASE 8 INHIBITOR; CASPASE 9; CASPASE INHIBITOR; CYCLOHEXIMIDE; CYTOCHROME C; DIZOCILPINE; FODRIN; ISOVELLERAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR BLOCKING AGENT; RUTHENIUM RED; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CELL DEATH; CELL LOSS; CELL NUCLEUS; CELL PROTECTION; CELL STRAIN MCF 7; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME RELEASE; GENETIC TRANSFECTION; GRANULE CELL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT; RAT; RECEPTOR BLOCKING;

AMIDOHYDROLASES; ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; CALCIUM; CALPAIN; CASPASES; CELLS, CULTURED; CYTOCHROMES C; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; NEURONS; POLYUNSATURATED ALKAMIDES; PROTEIN TRANSPORT; RATS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 5044241875     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401442     Document Type: Article

References (64)

1. Fride E (2002) Endocannabinoids in the central nervous system-an overview. Prostaglandins Leukot. Essent. Fatty Acids 66: 221-233
2. van der Stelt M, Veldhuis WB, Maccarrone M, Bar PR, Nicolay K, Veldink GA, Di Marzo V and Vliegenthart JF (2002) Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol. Neurobiol. 26: 317-346
3. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC and Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691
4. Hansen HS, Moesgaard B, Hansen HH, Schousboe A and Petersen G (1999) Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. Lipids 34: S327-S330
5. Maccarrone M and Finazzi-Agro A (2002) Endocannabinoids and their actions. Vitam. Horm. 65: 225-255
6. Thomas EA, Cravatt BF, Danielson PE, Gilula NB and Sutcliffe JG (1997) Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J. Neurosci. Res. 50: 1047-1052
7. Jacobsson SO and Fowler CJ (2001) Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br. J. Pharmacol. 132: 1743-1754
8. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol. 48: 443-450
9. Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H and Waku K (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275: 605-612
10. Olah Z, Karai L and Iadarola MJ (2001) Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J. Biol. Chem. 276: 31163-31170
11. Smart D, Jonsson KO, Vandevoorde S, Lambert DM and Fowler CJ (2002) 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br. J. Pharmacol. 136: 452-458
12. Smart D and Jerman JC (2000) Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol. Sci. 21: 134
13. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD and Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129: 227-230
14. Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ and Bickler PE (1998) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem. 70: 671-676
15. 2+ in endothelial cells. Br. J. Pharmacol. 126: 1593-1600
16. Jacobsson SO, Wallin T and Fowler CJ (2001) Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J. Pharmacol. Exp. Ther. 299: 951-959
17. Maccarrone M, Lorenzon T, Bari M, Melino G and Finazzi-Agro A (2000) Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275: 31938-31945
18. Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernandez-Ruiz JJ and Hansen HS (2001) Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J. Neurochem. 78: 1415-1427
19. Hansen HH, Ikonomidou C, Bittigau P, Hansen SH and Hansen HS (2001) Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J. Neurochem. 76: 39-46
20. Hansen HS, Moesgaard B, Petersen G and Hansen HH (2002) Putative neuroprotective actions of N-acyl-ethanolamines. Pharmacol. Ther. 95: 119-126
21. van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, Veldink GA, Viegenthart JF, Di Marzo V and Nicolay K (2001) Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J. Neurosci. 21: 8765-8771
22. Szallasi A, Blumberg PM, Annicelli LL, Krause JE and Cortright DN (1999) The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol. Pharmacol. 56: 581-587
23. Jerman JC, Brough SJ, Prinjha R, Harries MH, Davis JB and Smart D (2000) Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology. Br. J. Pharmacol. 130: 916-922
24. Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, Cairns W, Hayes PD, Randall AD and Davis JB (2001) Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur. J. Pharmacol. 417: 51-58
25. Gatley SJ, Gifford AN, Volkow ND, Lan R and Makriyannis A (1996) 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur. J. Pharmacol. 307: 331-338
26. Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A and Pertwee RG (1999) Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br. J. Pharmacol. 126: 665-672
27. Ueda Y, Katsuta K, Nakanishi H and Yoshida K (1995) Non-competitive NMDA antagonists, FR115427 and MK801, enhance neuronal survival in primary culture. Neurosci. Lett. 185: 107-110
28. Wiley JL, Dewey MA, Jefferson RG, Winckler RL, Bridgen DT, Willoughby KA and Martin BR (2000) Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sci. 67: 1573-1583
29. Fowler CJ, Borjesson M and Tiger G (2000) Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase. Br. J. Pharmacol. 131: 498-504
30. Movsesyan VA, Yakovlev AG, Dabaghyan EA, Stoica BA and Faden AI (2002) Ceramide induces neuronal apoptosis through the caspase-9/caspase-3 pathway. Biochem. Biophys. Res. Commun. 299: 201-207
31. Eldadah BA, Yakovlev AG and Faclen AI (1997) The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J. Neurosci. 17: 6105-6113
32. Nakajima M, Kashiwagi K, Ohta J, Furukawa S, Hayashi K, Kawashima T and Hayashi Y (1994) Etoposide induces programmed death in neurons cultured from the fetal rat central nervous system. Brain Res. 641: 350-352
33. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW and Thomrberry NA (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273: 32608-32613
34. Janicke RU, Sprengart ML, Wati MR and Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273: 9357-9360
35. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ and Thor AD (2001) Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 61: 348-354
36. Pike BR, Zhao X, Newcomb JK, Posmantur RM, Wang KK and Hayes RL (1998) Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport 9: 2437-2442
37. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, Mallard C and Hagberg H (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of pathological apoptosis? J. Biol. Chem. 276: 10191-10198
38. Brown TL, Patil S, Cianci CD, Morrow JS and Howe PH (1999) Transforming growth factor beta induces caspase 3-independent cleavage of alphaII-spectrin (alpha-fodrin) coincident with apoptosis. J. Biol. Chem. 274: 23256-23262
39. See V and Loeffler JP (2001) Oxidative stress induces neuronal death by recruiting a protease and phosphatase-gated mechanism. J. Biol. Chem. 276: 35049-35059
40. Chan SL and Mattson MP (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58: 167-190
41. Dutta S, Chiu YC, Probert AW and Wang KK (2002) Selective release of calpain produced alphaII-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. Biol. Chem. 383: 785-791
42. Wang KK, Posmantur R, Nath R, McGinnis K, Whitton M, Talanian RV, Glantz SB and Morrow JS (1998) Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J. Biol. Chem. 273: 22490-22497
43. Sato K, Saito Y and Kawashima S (1995) Identification and characterization of membrane-bound calpains in clathrin-coated vesicles from bovine brain. Eur. J. Biochem. 230: 25-31
44. Sprague J, Harrison C, Rowbotham DJ, Smart D and Lambert DG (2001) Temperature-dependent activation of recombinant rat vanillod VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. Eur. J. Pharmacol. 423: 121-125
45. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A and Di Marzo V (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem. 276: 12856-12863
46. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R and Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527-531
47. Sinor AD, Irvin SM and Greenberg DA (2000) Endocannabinods protect cerebral conical neurons from in vitro ischemia in rats. Neurosci. Lett. 278: 157-160
48. Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB and Smart D (2002) Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors. Br. J. Anaesth. 89: 882-887
49. Sarker KP and Maruyama I (2003) Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell Mol. Life Sci. 60: 1200-1208
50. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wanga X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
51. Noshita N, Lewen A, Sugawara T and Chan PH (2001) Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 21: 1442-1450
52. Dubois-Dauphin M, Pfister Y, Vallet PG and Savioz A (2001) Prevention of apoptotic neuronal death by controlling procaspases?. A point of view. Brain Res. Rev. 36: 196-203
53. Yakovlev AG, Ota K, Wang G, Movsesyan V, Bao WL, Yoshihara K and Facen AI (2001) Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J. Neurosci. 21: 7439-7446
54. Zhou H, Li XM, Meinkoth J and Pittman RN (2000) Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol. 151: 483-494
55. Deshmukh M and Johnson Jr. EM (1998) Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c [see comments]. Neuron 21: 695-705
56. Glassford A, Lee JE, Xu L and Giffard RG (2002) Caspase inhibitors reduce the apoptotic but not necrotic component of kainate injury in primary murine cortical neuronal cultures. Neurol. Res. 24: 796-800
57. Gil-Parrado S, Fernandez-Montalvan A, Assfalg-Machleidt I, Popp O, Bestvater F, Holloschi A, Knoch TA, Auerswald EA, Welsh K, Reed JC, Fritz H, Fuentes-Prior P, Spiess E, Salvesen GS and Machleidt W (2002) Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. J. Biol. Chem. 277: 27217-27226
58. Movsesyan VA, O'Leary DM, Fan L, Bao W, Mullins PG, Knoblach SM and Facen AI (2001) mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 296: 41-47
59. Toman R, Movsesyan V, Murthy S, Milstien S, Spiegel S and Faden A (2002) Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. J. Neurosci. Res. 68: 323-330
60. Pan G, O'Rourke K and Dixit VM (1998) Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273: 5841-5845
61. Sinensky MC, Leiser AL and Babich H (1995) Oxidative stress aspects of the cytotoxicity of carbamide peroxide: in vitro studies. Toxicol. Lett. 75: 101-109
62. Gomez C, Reiriz J, Pique M, Gil J, Ferrer I and Ambrosio S (2001) Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase- mediated apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 63: 421-428
63. Waterhouse NJ, Goldstein JC, Kluck RM, Newmeyer DD and Green DR (2001) The (Holey) study of mitochondria in apoptosis. Methods Cell Biol. 66: 365-391
64. Tovey SC, Dyer JL, Godfrey RE, Khan SZ, Bilmen JG, Mezna M and Michelangeli F (2000) Subtype identification and functional properties of inositol 1,4, 5- trisphosphate receptors in heart and aorta. Pharmacol. Res. 42: 581-590